Navigation Links
OncoGenex Reports Third Quarter Financial Results
Date:11/10/2008

cently filed Quarterly Report on Form 10-Q. No assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of the Company. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof.

Condensed Statements of Operations

(Unaudited)

(in thousands)

Three Months Nine Months

Ended Ended

September 30, September 30,

2008 2007 2008 2007

Operating expenses

Research and development $ 1,639 $ 1,094 $ 3,621 $ 3,075

General and administrative 1,024 609 2,243 2,709

------------------- -------------------

Total operating expenses 2,663 1,703 5,864 5,784

------------------- -------------------

Other income (expense) 297 (27) 88 44

------------------- -------------------

Loss for the period before taxes (2,366) (1,730) (5,776) (5,740)

Income tax expense (recovery) (2,515) 200 (2,100) 573

------------------- -------------------

Operating income (loss) before

extraordinary gain 149 (1,930) (3,676) (6,313)

Extraordinary gain 4,428 - 4,428 -

-------------------
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... With a larger, brighter interface, ... Cole-Parmer® Digital Gear Pump Drive for Micropump® ... for automated process applications. , Simply set time ... count function counts down and displays batches completed ... dispensed across multiple cycles. View the four operating ...
(Date:7/21/2014)... 2014 ResearchMoz presents this ... USA Cancer Biomaker Market to 2018 ... ResearchMoz presents this most up-to-date research on Global ... Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, ... GLOBAL & USA ...
(Date:7/18/2014)... 2014 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... and operating results on Tuesday, August 5, 2014, before ... a conference call and simultaneous webcast at 8:30 AM ... InformationTo access this call, dial (888) 660-6127 (U.S.) or ... be accessed from the ,Events and Presentations, page of ...
(Date:7/18/2014)... , July 18, 2014  Neurotrope, Inc. (OTCQB: NTRP) ... of Directors appointed Co-Chairmen Charles S. Ramat ... on an interim basis, effective immediately. Messrs. Ramat and ... no longer Chief Executive Officer of Neurotrope Bioscience, Inc., ... and whose employment agreement with Neurotrope Bioscience Inc. terminated ...
Breaking Biology Technology:New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 2Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 4
... China,Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," ... companies in the,People,s Republic of China ("PRC"), today ... was approved for quotation on the Over-the-Counter,Bulletin Board ... (FINRA)., "We are pleased to have our ...
... 4 Vical Incorporated,(Nasdaq: VICL ) today ... Executive Officer, will participate in a roundtable discussion,"An ... Engaging in,Global Health Product Development," and present an ... needs on Tuesday,March 11, at the Biotechnology Industry ...
... SAN DIEGO, March 4 SGX Pharmaceuticals,(Nasdaq: ... fourth quarter and,full year 2007 on Wednesday, March ... live conference call and webcast at 8:00 a.m. ... and Todd Myers, Chief,Financial Officer, will host the ...
Cached Biology Technology:China Biologic Products Commences Trading on OTC Bulletin Board 2Vical to Present at BIO and BVGH Global Health Partnering Event 2Vical to Present at BIO and BVGH Global Health Partnering Event 3SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results 2
(Date:7/21/2014)... A team of University of California, Riverside Bourns College of ... the grates of a backyard grill reduces by 70 percent ... The one-eighth inch thick steel carbon plate with an insulated ... a slit into the grill to allow the plate to ... by grill manufacturers who could sell new grills with the ...
(Date:7/21/2014)... Matriaux Tlcommunications Research Centre successfully imaged a chemical ... exceeding that obtained to date using microscopes. The ... a molecular movie of how an acetylene molecule ... was recently published in the scientific journal ... developed combines multiphoton ionization and Coulomb explosion imaging. ...
(Date:7/21/2014)... CAEating meat contributes to climate change, due to greenhouse ... emissions are on the rise and that beef cattle ... other types of animals. It is published by ... most-prevalent gas when it comes to climate change. It ... comprises the greatest portion of greenhouse gas totals. But ...
Breaking Biology News(10 mins):Catching grease to cut grill pollution 2Climate: Meat turns up the heat 2
... DURHAM, N.C. -- A magnetic separation technique developed by ... Purdue University makes it relatively simple to sort through ... the end of this sentence. The method ... testing, according to the researchers. For example, specially coated ...
... Elsevier, a leading publisher of scientific, technical and ... (NESLi2) have agreed to a four-year license for ScienceDirect, ... information. Key to the agreement is the high ... a product of the UKs Joint Information Systems Committee ...
... Ohio State University geologists and their colleagues have uncovered ... oxygen-rich atmosphere similar to the one we breathe today. ... crust initiated a kind of reverse-greenhouse effect 500 million ... plankton blooms, and sent a burst of oxygen into ...
Cached Biology News:New magnetic separation technique might detect multiple pathogens at once 2Researchers find origin of 'breathable' atmosphere half a billion years ago 2Researchers find origin of 'breathable' atmosphere half a billion years ago 3Researchers find origin of 'breathable' atmosphere half a billion years ago 4
...
Mol wt: monoisotopic mol wt1,045.5423 Da by calculation...
... for cell culture scale-up, these culture chambers ... - 10 9 range and are ... spinner flasks. • High mechanical • strength ... prior to shipping • Certified nonpyrogenic and ...
Anti 4-hydroxy-2-hexenal (4-HHE) Monoclonal Antibody (HNEJ-2)...
Biology Products: